Agha, A.; Afandi, B.; AlKaabi, S.; Alshkeili, N.A.N.S.; Alshemeili, M.A.A.; Ghaithi, M.M.A.; Alsaadi, M.M.H.; Alkaabi, J.
Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience. J. Clin. Med. 2025, 14, 6365.
https://doi.org/10.3390/jcm14186365
AMA Style
Agha A, Afandi B, AlKaabi S, Alshkeili NANS, Alshemeili MAA, Ghaithi MMA, Alsaadi MMH, Alkaabi J.
Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience. Journal of Clinical Medicine. 2025; 14(18):6365.
https://doi.org/10.3390/jcm14186365
Chicago/Turabian Style
Agha, Adnan, Bachar Afandi, Saeed AlKaabi, Naser Abdulla Naser Salem Alshkeili, Mohammed Ali Alsharoon Alshemeili, Mohammed Mohammed Al Ghaithi, Mohammad Mohammed Hareb Alsaadi, and Juma Alkaabi.
2025. "Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience" Journal of Clinical Medicine 14, no. 18: 6365.
https://doi.org/10.3390/jcm14186365
APA Style
Agha, A., Afandi, B., AlKaabi, S., Alshkeili, N. A. N. S., Alshemeili, M. A. A., Ghaithi, M. M. A., Alsaadi, M. M. H., & Alkaabi, J.
(2025). Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience. Journal of Clinical Medicine, 14(18), 6365.
https://doi.org/10.3390/jcm14186365
